Eli Lilly and Co
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by ...
Eli Lilly Zepbound, Mounjaro available after shortages, FDA says
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...
Drugmakers are racing to develop weight loss pills
Aykut Karahan | Istock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them ...
Brain implant Paradromics launches patient registry
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Aamir Ahmed ...
Novo Nordisk to boost output of Wegovy, Ozempic with new NC facility
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend ...
Eli Lilly expects FDA call on Zepbound for sleep apnea in near term
Eli Lilly on Friday said it applied for U.S. approval of its weight loss drug Zepbound for the treatment of the most ...
Digital health companies are launching programs around GLP-1s
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and ...
Eli Lilly invests to increase Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. ...
AstraZeneca to boost revenue, release new medicines by 2030
The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | ...
Amgen soars on weight loss drug progress, Novo Nordisk, Eli Lilly slide
Amgen‘s stock rose more than 12% on Friday after the drugmaker teased positive initial data on its experimental weight loss ...
